PANAGORA ASSET MANAGEMENT INC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 102 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,150,558
+6.7%
727,480
+6.1%
0.03%
+14.3%
Q2 2023$4,825,983
-16.4%
685,509
-0.9%
0.03%
-22.2%
Q1 2023$5,770,304
-27.7%
691,883
-0.5%
0.04%
-30.8%
Q4 2022$7,985,499
+26.1%
695,601
+38.4%
0.05%
+18.2%
Q3 2022$6,333,000
+55.2%
502,581
+30.3%
0.04%
+63.0%
Q2 2022$4,081,000
-36.0%
385,702
-1.6%
0.03%
-22.9%
Q1 2022$6,374,000
+40.5%
392,008
+19.7%
0.04%
+45.8%
Q4 2021$4,536,000
+41.3%
327,532
+46.6%
0.02%
+41.2%
Q3 2021$3,210,000
+6878.3%
223,406
+7577.2%
0.02%
Q2 2021$46,000
+820.0%
2,910
+500.0%
0.00%
Q1 2021$5,000
+150.0%
485
+44.8%
0.00%
Q4 2020$2,000
-99.1%
335
-98.8%
0.00%
-100.0%
Q1 2017$228,000
+14.6%
27,165
-13.7%
0.00%0.0%
Q4 2016$199,000
+43.2%
31,4770.0%0.00%0.0%
Q3 2016$139,000
+80.5%
31,477
+15.9%
0.00%
Q2 2016$77,000
-11.5%
27,165
+223.7%
0.00%
Q4 2015$87,000
+89.1%
8,393
+110.1%
0.00%
Q3 2015$46,000
-45.9%
3,995
-30.0%
0.00%
Q2 2015$85,000
-96.7%
5,708
-97.7%
0.00%
-100.0%
Q1 2014$2,605,000246,1900.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
VHCP Management II, LLC 6,071,142$38,430,00018.43%
RTW INVESTMENTS, LP 4,078,895$25,819,0009.72%
VHCP Management, LLC 1,155,104$7,312,0007.86%
RA Capital Management 2,989,795$18,925,0002.68%
DLD Asset Management, LP 1,258,700$7,967,0002.61%
Avoro Capital Advisors LLC 1,631,502$10,327,0002.09%
Ghost Tree Capital, LLC 1,150,000$7,280,0001.75%
GREAT POINT PARTNERS LLC 725,000$4,589,0000.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,237,734$20,495,0000.84%
Baker Brothers Advisors 10,963,944$69,402,0000.68%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders